Migraine Research Studies
This research study is evaluating the safety and effectiveness of an investigational study drug for the prevention of migraine in adults with episodic migraine.
Episodic Migraine (EM) which occurs less frequently than Chronic Migraine (CM) also has an impact on one’s quality of life and the need for alternative treatment options is essential to potentially help manage migraines in people suffering from EM.
This study may be an option for you if you:
- Are aged 18-65 years
- Have a history of migraine headache disorder
- Had migraine onset before 50 years of age
- Have 6-14 migraine days per month
- Have <15 headache days per month
Other criteria apply.
If you are eligible, your total involvement in the study may last up to 52 weeks (1 year) and you will receive study-related evaluations and care at no cost. You may be compensated for your time and travel.
Submit to learn more:
Please note: You may or may not benefit medically from taking part and you are able to opt at out anytime and do not have to give us a reason for doing so. Trial participation will be in collaboration with your GP.